Search
for
Sort by
Research 151–180 of 1000+
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata
- The fate of non-scalp hair in alopecia areata universalis under baricitinib treatment: A real-world single-center experience
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- Baricitinib as a treatment for myasthenia gravis: A case report
- Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Successful treatment of alopecia areata‐associated trachyonychia with baricitinib
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2
- There are early, gradual and late responders for scalp hair regrowth in patients with alopecia areata treated with baricitinib
- Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata